Biblioteca Digital de Teses e Dissertações PÓS-GRADUAÇÃO SCTRICTO SENSU Programa de Pós-Graduação em Educação Física
Use este identificador para citar ou linkar para este item: http://bdtd.uftm.edu.br/handle/tede/579
Registro completo de metadados
Campo DCValorIdioma
dc.creatorROSA, Kelly Cristina Paiva-
dc.creator.ID08528501663por
dc.contributor.advisor1VIRTUOSO JUNIOR, Jair Sindra-
dc.contributor.advisor1ID03476757609por
dc.contributor.advisor1Latteshttp://lattes.cnpq.br/2963442062396778por
dc.date.accessioned2018-08-06T13:49:30Z-
dc.date.issued2018-04-25-
dc.identifier.citationROSA, Kelly Cristina Paiva. Níveis de BDNF e leucócitos como marcadores de fragilidade em idosos: associação com fatores adversos à saúde, controlado pelo nível de atividade física. 2018. 67f. Dissertação (Mestrado em Educação Física) - Programa de Pós-Graduação em Educação Física, Universidade Federal do Triângulo Mineiro, Uberaba, 2018.por
dc.identifier.urihttp://bdtd.uftm.edu.br/handle/tede/579-
dc.description.resumoO objetivo do estudo foi estimar a prevalência e os fatores associados à fragilidade em idosos do município de Alcobaça, BA. Métodos: Estudo epidemiológico de corte transversal com amostra, estratificada de forma aleatória simples, de 241 indivíduos, com média de idade de 70,25 anos (DP=8,25) com amplitude de 60 e 97 anos, cadastrados nas Equipes de Saúde da Família (ESF) no aglomerado urbano de Alcobaça, Bahia, Brasil. A fragilidade foi definida pela presença concomitante de níveis séricos de BDNF ≤ P 25 (Percentil 25) e a contagem de Leucócitos inferior a 4.000 mm³ ou superior a 9.290 mm³. Para a análise dos dados foram utilizados procedimentos da estatística descritiva (frequência, média) e inferencial por meio da regressão de Poisson, p≤0,05. A prevalência de fragilidade foi de 8,7% e esta condição foi mais prevalente nos idosos hospitalizados nos últimos três meses e entre aqueles com incapacidade na realização das atividades básicas da vida diária, mesmo quando controlado por faixa etária, sexo e nível de atividade física. Os resultados encontrados neste estudo indicam que os idosos com ocorrência recente de hospitalização e aqueles com incapacidade funcional nas ABVD devem receber maior assistência e acompanhamento com a finalidade de evitar o agravamento nos fatores adversos à saúde e a evolução dos estágios preliminares para fragilidade avançada.por
dc.description.abstractObjective: The aim of the study was to estimate the prevalence and factors associated with frailty in the elderly in the city of Alcobaça, State of Bahia. METHODS: A cross-sectional epidemiological study of 241 individuals with a mean age of 70.25 years (SD = 8.25) with a range of 60 and 97 years, enrolled in the Health Family (ESF) in the urban agglomeration of Alcobaça, Bahia, Brazil. Fragility was defined by the concomitant presence of serum BDNF ≤ P 25 (Percentile 25) and the Leukocyte count below 4,000 mm³ or greater than 9,290 mm³. Data analysis was performed using descriptive statistics (frequency, mean) and inferential statistics using Poisson regression, p≤0.05. The prevalence of frailty was 8.7% and this condition was more prevalent in the elderly hospitalized in the last three months and among those with disabilities in performing the basic activities of daily living, even when controlled by age, gender and level of physical activity. The results found in this study indicate that the elderly with a recent hospitalization and those with functional disability in the ABVD should receive more assistance and follow-up in order to avoid aggravation in adverse health factors and the evolution from the preliminary stages to advanced fragility.eng
dc.formatapplication/pdf*
dc.thumbnail.urlhttp://bdtd.uftm.edu.br/retrieve/3541/Dissert%20Kelly%20C%20P%20Rosa.pdf.jpg*
dc.languageporpor
dc.publisherUniversidade Federal do Triângulo Mineiropor
dc.publisher.departmentInstituto de Ciências da Saúde - ICS::Curso de Graduação em Educação Físicapor
dc.publisher.countryBrasilpor
dc.publisher.initialsUFTMpor
dc.publisher.programPrograma de Pós-Graduação em Educação Físicapor
dc.relation.referencesAN, J. J. et al. Distinct role of long 3’ UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons. Cell, v. 134, n. 1, p. 175–187, 11 jul. 2008. ANDRADE, A. DO N. et al. Análise do conceito fragilidade em idosos. Texto & Contexto - Enfermagem, v. 21, n. 4, p. 748–756, dez. 2012. ANGELUCCI, F. et al. Alzheimer’s disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels. Current Alzheimer Research, v. 7, n. 1, p. 15–20, fev. 2010. BEKINSCHTEIN, P. et al. BDNF and memory formation and storage. The Neuroscientist: A Review Journal Bringing Neurobiology, Neurology and Psychiatry, v. 14, n. 2, p. 147–156, abr. 2008. BODNER, S. M. et al. Genetic variation in the brain derived neurotrophic factor gene in Alzheimer’s disease. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics, v. 134B, n. 1, p. 1–5, 5 abr. 2005. BOVILL, E. G. et al. White blood cell counts in persons aged 65 years or more from the Cardiovascular Health Study. Correlations with baseline clinical and demographic characteristics. American Journal of Epidemiology, v. 143, n. 11, p. 1107–1115, 1 jun. 1996. BUCHNER, D. M.; WAGNER, E. H. Preventing frail health. Clinics in Geriatric Medicine, v. 8, n. 1, p. 1–17, fev. 1992. CARNEIRO, J. A. et al. Frailty in the elderly: prevalence and associated factors. Revista Brasileira De Enfermagem, v. 70, n. 4, p. 747–752, ago. 2017. CHARANSONNEY, O. L. Physical activity and aging: a life-long story. Discovery Medicine, v. 12, n. 64, p. 177–185, set. 2011. CHEN, Z.-Y. et al. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, v. 24, n. 18, p. 4401–4411, 5 maio 2004. COUNSELL, S. R. et al. Effects of a multicomponent intervention on functional outcomes and process of care in hospitalized older patients: a randomized controlled trial of Acute Care for Elders (ACE) in a community hospital. Journal of the American Geriatrics Society, v. 48, n. 12, p. 1572–1581, dez. 2000. COVINSKY, K. E. et al. Loss of independence in activities of daily living in older adults hospitalized with medical illnesses: increased vulnerability with age. Journal of the American Geriatrics Society, v. 51, n. 4, p. 451–458, abr. 2003. CRUZ, D. T. DA et al. Factors associated with frailty in a community-dwelling population of older adults. Revista De Saude Publica, v. 51, p. 106, 2017. DATASUS. Informações de Saúde (TABNET)- Demográficas e Socioeconômicas. Disponível em: <http://www2.datasus.gov.br/DATASUS/index.php?area=0206&VObj=http://tabnet.da tasus.gov.br/cgi/deftohtm.exe?ibge/cnv/pop>. Acesso em: 15 abr. 2018. DESAI, P. et al. Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer’s disease (AD) and quantitative measures of AD progression. Neuroscience Letters, v. 379, n. 3, p. 229–234, 13 maio 2005. DÍAZ DE LEÓN GONZÁLEZ, E. et al. [Frailty and its association with mortality, hospitalization and functional dependence in Mexicans aged 60-years or older]. Medicina Clinica, v. 138, n. 11, p. 468–474, 28 abr. 2012. DINIZ, B. S.; TEIXEIRA, A. L. Brain-derived neurotrophic factor and Alzheimer’s disease: physiopathology and beyond. Neuromolecular Medicine, v. 13, n. 4, p. 217–222, dez. 2011. DUTRA, LIEGE SILVEIRA; SANTOS, ANA FLÁVIA DOS; WERLANG, SUELI TEREZINHA. Assistência pós-alta hospitalar para pacientes com cuidados especiais. Boletim de Saúde - ESP/RS, v. 18, n. 2, p. 25–28, jul. 2004. EGAN, M. F. et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, v. 112, n. 2, p. 257–269, 24 jan. 2003. ERICKSON, K. I. et al. Genetic contributions to age-related decline in executive function: a 10-year longitudinal study of COMT and BDNF polymorphisms. Frontiers in Human Neuroscience, v. 2, p. 11, 2008. ERSHLER, W. B.; KELLER, E. T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annual Review of Medicine, v. 51, p. 245– 270, 2000. ESPINOZA, S.; WALSTON, J. D. Frailty in older adults: insights and interventions. Cleveland Clinic Journal of Medicine, v. 72, n. 12, p. 1105–1112, dez. 2005. ESPÓSITO, D. L. A. Alterações genéticas em linfócitos de pacientes portadores da síndrome da fragilidade. 2010. 71 f. Dissertação (Mestrado em Genética) – Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, 2010. FABRÍCIO – WEHB, S.C.C. Adaptação cultural e validação da “Edmonton Frail Escale” (EFS) - escala de avaliação de fragilidade em idosos [tese]. Ribeirão Preto (SP): Universidade de São Paulo, Escola de Enfermagem de Ribeirão Preto; 2008. FARIA, M. C. et al. Increased plasma levels of BDNF and inflammatory markers in Alzheimer’s disease. Journal of Psychiatric Research, v. 53, p. 166–172, jun. 2014. FEHÉR, A. et al. Association between BDNF Val66Met polymorphism and Alzheimer disease, dementia with Lewy bodies, and Pick disease. Alzheimer Disease and Associated Disorders, v. 23, n. 3, p. 224–228, set. 2009. FREITAS, R. S. et al. Functional capacity and associated factors in the elderly: a population study. Acta Paulista de Enfermagem, v. 25, n. 6, p. 933–939, jan. 2012. FRIED, L. P. et al. Frailty in older adults: evidence for a phenotype. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, v. 56, n. 3, p. M146–156, mar. 2001. FRIED, L. P. et al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, v. 59, n. 3, p. 255–263, mar. 2004. FUMAGALLI, F.; RACAGNI, G.; RIVA, M. A. The expanding role of BDNF: a therapeutic target for Alzheimer’s disease? The Pharmacogenomics Journal, v. 6, n. 1, p. 8–15, fev. 2006. GILLICK, M. Pinning down frailty. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, v. 56, n. 3, p. M134–135, mar. 2001. HALLAL, P. C. et al. Global physical activity levels: surveillance progress, pitfalls, and prospects. Lancet (London, England), v. 380, n. 9838, p. 247–257, 21 jul. 2012. HOFER, M. et al. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. The EMBO journal, v. 9, n. 8, p. 2459–2464, ago. 1990. HONG, C.-J.; LIOU, Y.-J.; TSAI, S.-J. Effects of BDNF polymorphisms on brain function and behavior in health and disease. Brain Research Bulletin, v. 86, n. 5-6, p. 287–297, 25 nov. 2011. HUANG, E. J.; REICHARDT, L. F. Neurotrophins: roles in neuronal development and function. Annual Review of Neuroscience, v. 24, p. 677–736, 2001. INGLÉS, M. et al. Brain-Derived Neurotrophic Factor as a Marker of Cognitive Frailty. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, v. 72, n. 3, p. 450–451, 1 mar. 2017. KATZ, S. et al. STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. JAMA, v. 185, p. 914–919, 21 set. 1963. KO, F. C.-Y. The clinical care of frail, older adults. Clinics in Geriatric Medicine, v. 27, n. 1, p. 89–100, fev. 2011. KOHL, H. W. et al. The pandemic of physical inactivity: global action for public health. Lancet (London, England), v. 380, n. 9838, p. 294–305, 21 jul. 2012. KRABBE, K. S.; PEDERSEN, M.; BRUUNSGAARD, H. Inflammatory mediators in the elderly. Experimental Gerontology, v. 39, n. 5, p. 687–699, maio 2004. LASKE, C. et al. Stage-dependent BDNF serum concentrations in Alzheimer’s disease. Journal of Neural Transmission (Vienna, Austria: 1996), v. 113, n. 9, p. 1217–1224, set. 2006. LAVINSKY, A. E.; VIEIRA, T. T. Processo de cuidar de idosos com acidente vascular encefálico: sentimentos dos familiares envolvidos - DOI: 10.4025/actascihealthsci.v26i1.1614. Acta Scientiarum. Health Sciences, v. 26, n. 1, p. 41–45, 4 abr. 2008. LAWTON, M. P.; BRODY, E. M. Assessment of older people: self-maintaining and instrumental activities of daily living. The Gerontologist, v. 9, n. 3, p. 179–186, 1969. LEE, L. K. et al. Prevalence of gender disparities and predictors affecting the occurrence of mild cognitive impairment (MCI). Archives of Gerontology and Geriatrics, v. 54, n. 1, p. 185–191, fev. 2012. LENG, S. et al. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. Journal of the American Geriatrics Society, v. 50, n. 7, p. 1268–1271, jul. 2002. LENG, S. X. et al. Baseline total and specific differential white blood cell counts and 5-year all-cause mortality in community-dwelling older women. Experimental Gerontology, v. 40, n. 12, p. 982–987, dez. 2005. LENG, S. X. et al. Inflammation and frailty in older women. Journal of the American Geriatrics Society, v. 55, n. 6, p. 864–871, jun. 2007. LENG, S. X. et al. White blood cell counts, insulin-like growth factor-1 levels, and frailty in community-dwelling older women. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, v. 64, n. 4, p. 499–502, abr. 2009. LEYHE, T. et al. Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer’s disease. European Archives of Psychiatry and Clinical Neuroscience, v. 258, n. 2, p. 124–128, mar. 2008. LINO, V. T. S. et al. [Cross-cultural adaptation of the Independence in Activities of Daily Living Index (Katz Index)]. Cadernos De Saude Publica, v. 24, n. 1, p. 103– 112, jan. 2008. MALAGUARNERA, M. et al. What is the frailty in elderly? Value and significance of the multidimensional assessments. Archives of Gerontology and Geriatrics, v. 56, n. 1, p. 23–26, fev. 2013. MARGOLIS, K. L. et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women’s Health Initiative Observational Study. Archives of Internal Medicine, v. 165, n. 5, p. 500–508, 14 mar. 2005. MARIN, M. J. S. et al. Características sócio-demográficas do atendimento ao idoso após alta hospitalar na Estratégia da Saúde de Família. Revista da Escola de Enfermagem da USP, v. 44, n. 4, p. 962–968, dez. 2010. MARRA, C. C. et al. Orientaçäo planejada de enfermagem na alta hospitalar. Acta paul. enferm, p. 123–7, 1989. MATTSON, M. P.; MAUDSLEY, S.; MARTIN, B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends in Neurosciences, v. 27, n. 10, p. 589–594, out. 2004. MILLÁN-CALENTI, J. C. et al. Prevalence of functional disability in activities of daily living (ADL), instrumental activities of daily living (IADL) and associated factors, as predictors of morbidity and mortality. Archives of Gerontology and Geriatrics, v. 50, n. 3, p. 306–310, jun. 2010. MORLEY, J. E.; PERRY, H. M.; MILLER, D. K. Editorial: Something about frailty. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, v. 57, n. 11, p. M698–704, nov. 2002. NACMIAS, B. et al. Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer’s disease. Neuroscience Letters, v. 367, n. 3, p. 379–383, 9 set. 2004. NAGATA, T. et al. Association between BDNF polymorphism (Val66Met) and executive function in patients with amnestic mild cognitive impairment or mild Alzheimer disease. Dementia and Geriatric Cognitive Disorders, v. 33, n. 4, p. 266–272, 2012. O’BRYANT, S. E. et al. Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer’s disease cases. Dementia and Geriatric Cognitive Disorders, v. 31, n. 1, p. 31–36, 2011. PEARSON, T. A. et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, v. 107, n. 3, p. 499–511, 28 jan. 2003. PITANGA, F.; LESSA, I. Association between leisure-time physical activity and Creactive protein levels in adults, in the city of Salvador, Brazil. Arquivos Brasileiros De Cardiologia, v. 92, n. 4, p. 302–306, abr. 2009. PODRAZIK, P. M.; WHELAN, C. T. Acute hospital care for the elderly patient: its impact on clinical and hospital systems of care. The Medical Clinics of North America, v. 92, n. 2, p. 387–406, ix, mar. 2008. POMPEO, D. A. et al. Nurses’ performance on hospital discharge: patients’ point of view. Acta Paulista de Enfermagem, v. 20, n. 3, p. 345–350, set. 2007. RANTANEN, T. et al. Handgrip strength and cause-specific and total mortality in older disabled women: exploring the mechanism. Journal of the American Geriatrics Society, v. 51, n. 5, p. 636–641, maio 2003. RODRIGUES, R. A. P.; PEDRAZZI, E. C.; SCHIAVETO, F. V. Morbidade referida e capacidade funcional de idosos. Ciência, Cuidado e Saúde, v. 6, n. 4, p. 407–413, 29 maio 2008. RUGGIERO, C. et al. White blood cell count and mortality in the Baltimore Longitudinal Study of Aging. Journal of the American College of Cardiology, v. 49, n. 18, p. 1841–1850, 8 maio 2007. SALVI, F. et al. Screening for frailty in elderly emergency department patients by using the Identification of Seniors At Risk (ISAR). The Journal of Nutrition, Health & Aging, v. 16, n. 4, p. 313–318, abr. 2012. SANTOS, A. A. DOS; PAVARINI, S. C. I. Functionality of elderly people with cognitive impairments in different contexts of social vulnerability. Acta Paulista de Enfermagem, v. 24, n. 4, p. 520–526, jan. 2011. SANTOS, R. L. DOS; JÚNIOR, J. S. V. Confiabilidade Da Versão Brasileira Da Escala De Atividades Instrumentais Da Vida Diária. Revista Brasileira em Promoção da Saúde, v. 21, n. 4, p. 290–296, 2008. SCHINDOWSKI, K.; BELARBI, K.; BUÉE, L. Neurotrophic factors in Alzheimer’s disease: role of axonal transport. Genes, Brain, and Behavior, v. 7 Suppl 1, p. 43– 56, fev. 2008. SILVA, K. L. et al. Home care in the Brazilian National Health System (SUS). Revista de Saúde Pública, v. 39, n. 3, p. 391–397, jun. 2005. TAPIA-ARANCIBIA, L. et al. New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Research Reviews, v. 59, n. 1, p. 201–220, nov. 2008. TARAZONA, R. et al. Basic biology and clinical impact of immunosenescence. Experimental Gerontology, v. 37, n. 2-3, p. 183–189, mar. 2002. TAVARES, D. M. D. S. et al. Frailty Syndrome in Association with Depressive Symptoms and Functional Disability among Hospitalized Elderly. Issues in Mental Health Nursing, p. 1–6, 5 mar. 2018. TONET, A. C.; NÓBREGA, O. DE T. Imunossenescência: a relação entre leucócitos, citocinas e doenças crônicas. Revista Brasileira de Geriatria e Gerontologia, v. 11, n. 2, p. 259–273, ago. 2008. TORRES K.C.D. et al. Imunossenescência. Geriatria & Gerontologia. Rio de Janeiro, v. 5, n.3, p.163-69, 2011. VENTRIGLIA, M. et al. Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer’s disease. Molecular Psychiatry, v. 7, n. 2, p. 136–137, 2002. VIRTUOSO JÚNIOR, J. S. et al. Time Spent Sitting Is Associated with Changes in Biomarkers of Frailty in Hospitalized Older Adults: A Cross Sectional Study. Frontiers in Physiology, v. 8, p. 505, 2017. VIRTUOSO JÚNIOR, J.S. et al. Prevalência de incapacidade funcional e fatores associados em idosos. Texto & Contexto - Enfermagem, v. 24, n. 2, p. 521–529, jun. 2015. VOINESKOS, A. N. et al. The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease. Archives of General Psychiatry, v. 68, n. 2, p. 198–206, fev. 2011. WALSTON, J. et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Archives of Internal Medicine, v. 162, n. 20, p. 2333–2341, 11 nov. 2002a. WALSTON, J. et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Archives of Internal Medicine, v. 162, n. 20, p. 2333–2341, 11 nov. 2002b. WHO. Global Recommendations on Physical Activity for Health. Geneva: World Health Organization, 2010. WOOLLEY, J. D. et al. BDNF serum concentrations show no relationship with diagnostic group or medication status in neurodegenerative disease. Current Alzheimer Research, v. 9, n. 7, p. 815–821, set. 2012. YAO, X.; LI, H.; LENG, S. X. Inflammation and immune system alterations in frailty. Clinics in Geriatric Medicine, v. 27, n. 1, p. 79–87, fev. 2011. ZELADA, M. A.; SALINAS, R.; BAZTÁN, J. J. Reduction of functional deterioration during hospitalization in an acute geriatric unit. Archives of Gerontology and Geriatrics, v. 48, n. 1, p. 35–39, fev. 2009. ZHANG, F. et al. Roles of brain-derived neurotrophic factor/tropomyosin-related kinase B (BDNF/TrkB) signalling in Alzheimer’s disease. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia, v. 19, n. 7, p. 946–949, jul. 2012.por
dc.rightsAcesso Abertopor
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.subjectFator Neurotrófico Derivado do Encéfalo.por
dc.subjectIdoso Fragilizado.por
dc.subjectAtividade física.por
dc.subjectBrain derived neurotrofic fator.eng
dc.subjectFrail Elderly.eng
dc.subjectPhysical Activityeng
dc.subject.cnpqEducação Físicapor
dc.titleNíveis de BDNF e leucócitos como marcadores de fragilidade em idosos: associação com fatores adversos à saúde, controlado pelo nível de atividade física.por
dc.typeDissertaçãopor
Aparece nas coleções:Programa de Pós-Graduação em Educação Física

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
Dissert Kelly C P Rosa.pdfDissert Kelly C P Rosa1,71 MBAdobe PDFThumbnail
Visualizar/Abrir
Mostrar registro simples do item Visualizar estatísticas


Este item está licenciada sob uma Licença Creative Commons Creative Commons